Previous studies have shown that PTBP3 is dysregulated and promotes the progression of numerous cancers, including breast cancer [6], hepatocellular cancer [7], gastric cancer [8] and CRC [9]. This evidence concerns the gene PTBP3 and hepatocellular carcinoma.